
Chinese Researchers Find Immune Cell Fueling Chronic Sinusitis
Researchers from China’s Tsinghua University have discovered that a specific immune cell contributes to chronic sinusitis and nasal polyps, offering new hope for effective treatments.
News & Insights Across Asia
Stay informed on China’s evolving landscape—from social topics and technological innovations to sports and major national events—highlighting its impact on the global stage.
Researchers from China’s Tsinghua University have discovered that a specific immune cell contributes to chronic sinusitis and nasal polyps, offering new hope for effective treatments.
Chinese scientists have identified Granzyme K, a protein secreted by specific immune cells, as a key factor in chronic sinus infections, offering hope for more effective treatments.
Chinese researchers have discovered that a specific immune cell secreting Granzyme K fuels persistent inflammation in chronic sinusitis and nasal polyps, offering a potential new drug target.
Scientists discovered that a type of immune cell worsens chronic sinus infections, paving the way for new treatments targeting Granzyme K to reduce inflammation and recurrence.
Scientists in China have discovered that Granzyme K, a protein from specific immune cells, fuels chronic sinusitis and nasal polyps, offering new hope for effective treatments.
Scientists from China’s Tsinghua University and Beijing Tongren Hospital have identified a specific immune cell that fuels chronic sinus infections, offering new hope for effective treatments.
Researchers from Tsinghua University and Beijing Tongren Hospital have identified an immune cell that intensifies chronic sinusitis, potentially leading to new treatments for millions worldwide.
Chinese scientists have discovered that a specific type of immune cell secreting Granzyme K worsens chronic sinusitis and nasal polyps by intensifying inflammation, offering new targets for treatment.
Researchers from China’s Tsinghua University and Beijing Tongren Hospital have discovered that Granzyme K, secreted by specialized immune cells, worsens chronic sinusitis and nasal polyps.
Scientists from China’s Tsinghua University and Beijing Tongren Hospital have discovered that certain immune cells worsen chronic sinusitis, offering new hope for improved treatments.
A new study from China’s Tsinghua University and Beijing Tongren Hospital reveals that Granzyme K, a protein secreted by specialized immune cells, fuels chronic sinus infections.
Scientists from Tsinghua University and Beijing Tongren Hospital have found that a specific immune cell secreting Granzyme K exacerbates chronic sinusitis, opening new avenues for treatment.
Researchers from China’s Tsinghua University and Beijing Tongren Hospital have identified Granzyme K, a protein secreted by specialized immune cells, as a key factor worsening chronic sinusitis.
Chinese researchers have discovered that a specific immune cell secreting Granzyme K intensifies chronic sinusitis and nasal polyps, offering hope for new treatments.
Chinese scientists have discovered that a specific immune cell worsens chronic sinusitis by intensifying inflammation, offering a new target for treatment and hope for millions affected.
In a groundbreaking study, researchers from China’s Tsinghua University and Beijing Tongren Hospital have identified an immune cell that worsens chronic sinus infections, offering new hope for effective treatments.
Chinese scientists have discovered that a specific immune cell secreting Granzyme K fuels chronic sinus infections, paving the way for new treatments.
Chinese scientists have discovered that a specific immune cell, secreting Granzyme K, fuels chronic sinus infections, offering new hope for targeted treatments.
Scientists from China’s Tsinghua University and Beijing Tongren Hospital have identified Granzyme K, an immune protein that worsens inflammation in chronic sinusitis and nasal polyps.
Scientists discover Granzyme K, secreted by specialized immune cells, intensifies inflammation in chronic sinusitis and nasal polyps, opening new avenues for treatment.